MTCH2 Knockout Cell Line (HEK293)

The choice depends on whether you are studying MTCH2 (mitochondrial carrier homolog 2)'s role as a mitochondrial outer membrane protein insertase or its functions in mitochondrial biology and apoptosis. The Knockout line is the standard tool for asking whether MTCH2 is required for these processes — MTCH2 was recently characterized as a major mitochondrial outer membrane (MOM) protein insertase (a 'mitochondrial translocase'), inserting α-helical MOM proteins into the lipid bilayer; this is in addition to MTCH2's longer-known roles in tBID-induced apoptosis and adipocyte differentiation. Overexpression is useful for studying MTCH2 in heterologous contexts. For mitochondrial biology research, the EDITGENE MTCH2 Knockout in HEK293 is highly informative — the recent discovery that MTCH2 acts as a major MOM protein insertase represents a paradigm shift in understanding mitochondrial protein import. Rescue with wild-type or insertase-deficient MTCH2 enables structure-function studies of this newly characterized translocase activity. The knockout is valuable for studying mitochondrial proteome biogenesis, apoptosis regulation (tBID-MTCH2 interaction releases cytochrome c), and adipocyte biology (MTCH2 has been characterized in adipogenesis).

Primary applications: • MOM protein insertion: α-helical mitochondrial outer membrane protein integration assays following MTCH2 loss — particularly TOM20, GDAP1, FIS1, and other tail-anchored MOM proteins. • Mitochondrial proteome profiling: mass spectrometry analysis of mitochondrial proteome changes in MTCH2-null cells given MTCH2's translocase function. • Apoptosis regulation: tBID-induced mitochondrial outer membrane permeabilization (MOMP), cytochrome c release, and caspase activation given MTCH2's tBID receptor function. • Adipogenesis studies: in heterologous adipocyte-relevant contexts, MTCH2's roles in adipocyte differentiation. EDITGENE recommends this model for researchers investigating mitochondrial outer membrane biogenesis, MTCH2 translocase function, and apoptosis-mitochondria intersection biology.

Yes. MTCH2 rescue experiments require attention to mitochondrial outer membrane targeting: • Construct design: use a codon-modified MTCH2 sequence with a small C-terminal tag (FLAG, HA). MTCH2 has the mitochondrial carrier family architecture (six transmembrane domains) — preserve topology for proper MOM insertion. • Insertase-deficient rescue: structure-function mutations affecting the recently characterized MOM protein insertase activity enable separation of insertase from other MTCH2 functions. • tBID-binding-deficient rescue: specific mutations affecting tBID interaction enable separating apoptosis-related from translocase functions. • Functional readout: rescue should restore mitochondrial proteome composition, tBID-induced MOMP, and apoptosis responses. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.